Tirzepatide often shows faster and more substantial results compared to other weight loss medications
[82] In December 2017, the injectable version with the brand name Ozempic was approved in the US for use by people with diabetes, [30] [83] and, in January 2018, in Canada
Microdosing is ideal for individuals with mild weight concerns, appetite challenges, or previous side effects from higher doses
Acute kidney injury and lactic acidosis are additional common Janumet side effects listed in FAERS
Any future introduction of retatrutide would need to be supported by adequate prescribing infrastructure, likely within Tier 3 or Tier 4 specialist weight management services, as outlined in NHS England's obesity care pathways
At our wellness center , we understand that deciding on the right medication involves considering both the cost and potential side effects